Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-30

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved an Original Application for dexmethylphenidate hydrochloride, a generic ADHD medication, manufactured by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)